Picture of Fagron NV logo

FAGR Fagron NV News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareConservativeMid CapHigh Flyer

Brief: Fagron FY REBITDA Down At 118.3 Million Euros

Feb 10 (Reuters) - Fagron NV  FAGRO.BR :
    * FY TURNOVER EUR 573,80 MILLION, UP 3.2% 
    * FY NET PROFIT ROSE 2.2 PERCENT TO 61.4 MILLION EUR
    * FY REVENUE ROSE 3.2 PERCENT TO 573.8 MILLION EUR
    * FULL YEAR '21 RESULTS FAGRON IN LINE WITH EXPECTATIONS
    * FY TURNOVER INCREASED 3.2% TO EUR 573.8 MILLION (5.9% CER)
    * FY REBITDA DECREASED 4.5% TO EUR 118.3 MILLION (-1.5% CER)
    * FY NET PROFIT INCREASED 2.2% TO EUR 61.4 MILLION
    * END-FY OPERATING CASH FLOW OF EUR 78.4 MILLION
    * NET FINANCIAL DEBT/REBITDA RATIO OF 2.11 AT YEAR END 2021
    * DIVIDEND PROPOSAL OF EUR 0.20 PER SHARE
    * OPERATIONAL WORKING CAPITAL IMPROVED VERSUS H1 2021 TO
10.3% OF
TURNOVER
    * FAGRON STRENGTHENS POSITION IN BELGIAN MARKET WITH
ACQUISITION
OF PHARMA-PACK AND MINORITY STAKE IN HEW PHARMA
    * BOARD OF DIRECTORS INTENDS TO SUBMIT APPOINTMENT OF ANN
DESENDER
AS INDEPENDENT AND NON-EXECUTIVE DIRECTOR
    * FAGRON REALIZED GOOD TURNOVER GROWTH OF 9.3%, DESPITE
DEMAND FOR
COVID-19 RELATED PRODUCTS FADING IN 2021 - CEO SAYS

Source text for Eikon:  ID:nGNE5dwpc6 
Further company coverage:  FAGRO.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Fagron NV

See all news